‘Gujarat’s brain stroke trend worrying’

AHMEDABAD: Like Gujarat’s reputation as capital of cardio-vascular complications in India, experts are pointing at another direction where the trend can be worrisome – brain stroke which can have implications ranging from paralysis to death. Both the complications have similar factors leading to it – hypertension, hyperlipidemia (increased cholesterol) and tobacco abuse.

Dr Anand Vaishnav, a neurologist associated with Vadodara Institute of Neurological Sciences, delivered a talk titled ‘Stroke Scenario in India’ on the last day of three-day SNVICON 2018 – third annual congress of Neuro Vascular Interventions and Stroke CME. Vaishnav said that hypertension, hyperlipidemia and tobacco abuse are the commonest risk factors in Gujarati population.

“Another interesting factor is that we have high levels of homocysteine – an amino acid – in our blood. The levels get high in patients with deficiency of vitamins B12, B6 and folic acid. Our vegetarian diet, type of cooking and genetics would be contributing factors causing hyperhomocysteinemia – the condition that can lead to cardiovascular and stroke risks,” said Vaishnav.

Dr Vaishnav mentioned that India records about 15 lakh ischemic strokes per year out of which only 14,000-odd or less than 1% get thrombolysis – treatment for breaking down the blood clots causing it. “One in every six persons is susceptible to brain stroke. Females are more prone to having the strokes compared to males. Only about half the population is aware of its symptoms,” he said, adding that India has observed increase of about 100% in four decades.

About 400 medical practitioners participated in the event where the focus was on creating awareness about initiatives such as National Program on Prevention and Control of Cardiovascular Disease (NPCDCS) and saving lives during golden period of 4.5 hours after a person shows signs of stroke.

Dr Mukesh Sharma, organizing secretary of the event, said, “On Sunday, about 150 general practitioners and emergency medicine experts were also invited for a training session to improve awareness about the symptoms and course of treatment.”

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions